164 related articles for article (PubMed ID: 3709074)
1. The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialysed patients.
Wolthers BG; Meijer S; Tepper T; Hayer M; Elzinga H
Clin Sci (Lond); 1986 Jul; 71(1):41-7. PubMed ID: 3709074
[TBL] [Abstract][Full Text] [Related]
2. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
[TBL] [Abstract][Full Text] [Related]
3. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
Watts RW; Veall N; Purkiss P
Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
[TBL] [Abstract][Full Text] [Related]
4. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
[TBL] [Abstract][Full Text] [Related]
5. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
[TBL] [Abstract][Full Text] [Related]
6. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.
Hoppe B; Graf D; Offner G; Latta K; Byrd DJ; Michalk D; Brodehl J
Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249
[TBL] [Abstract][Full Text] [Related]
7. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
[TBL] [Abstract][Full Text] [Related]
8. Urinary oxalate and glycolate excretion and plasma oxalate concentration.
Barratt TM; Kasidas GP; Murdoch I; Rose GA
Arch Dis Child; 1991 Apr; 66(4):501-3. PubMed ID: 2031609
[TBL] [Abstract][Full Text] [Related]
9. Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.
Tomson CR; Channon SM; Parkinson IS; Morley AR; Lennard TW; Parrott NR; Laker MF
J Clin Pathol; 1988 Oct; 41(10):1107-13. PubMed ID: 3192733
[TBL] [Abstract][Full Text] [Related]
10. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both.
Constable AR; Joekes AM; Kasidas GP; O'Regan P; Rose GA
Clin Sci (Lond); 1979 Apr; 56(4):299-304. PubMed ID: 477214
[TBL] [Abstract][Full Text] [Related]
11. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
[TBL] [Abstract][Full Text] [Related]
12. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
Hoppe B; Beck B; Gatter N; von Unruh G; Tischer A; Hesse A; Laube N; Kaul P; Sidhu H
Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020
[TBL] [Abstract][Full Text] [Related]
13. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
Tomson CR; Channon SM; Ward MK; Laker MF
Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics of oxalate in hemodialysis].
Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
[TBL] [Abstract][Full Text] [Related]
15. Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1.
Yamauchi T; Quillard M; Takahashi S; Nguyen-Khoa M
Nephrol Dial Transplant; 2001 Dec; 16(12):2407-11. PubMed ID: 11733634
[TBL] [Abstract][Full Text] [Related]
16. Ion chromatographic determination of plasma oxalate in healthy subjects, in patients with chronic renal failure and in cases of hyperoxaluric syndromes.
Petrarulo M; Bianco O; Marangella M; Pellegrino S; Linari F; Mentasti E
J Chromatogr; 1990 Jul; 511():223-31. PubMed ID: 2211912
[TBL] [Abstract][Full Text] [Related]
17. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
[TBL] [Abstract][Full Text] [Related]
18. Assay of plasma oxalate with soluble oxalate oxidase.
Petrarulo M; Cerelli E; Marangella M; Cosseddu D; Vitale C; Linari F
Clin Chem; 1994 Nov; 40(11 Pt 1):2030-4. PubMed ID: 7955374
[TBL] [Abstract][Full Text] [Related]
19. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
[TBL] [Abstract][Full Text] [Related]
20. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
